Paratek Pharmaceuticals is a biopharmaceutical company dedicated to the development and commercialization of innovative products to treat serious infections. Their portfolio includes therapies that target resistant pathogens, addressing critical unmet medical needs in infectious disease. Paratek is committed to improving patient outcomes by prioritizing scientific integrity and collaboration across various healthcare stakeholders. With a strong emphasis on core values such as resourcefulness, collaboration, passion, and purpose, the company strives to foster a culture that encourages teamwork and a shared commitment to excellence. Paratek's goal is to make impactful contributions to global health by enhancing the therapeutic options available to patients while maintaining a focus on compliance and ethical practices in all business activities.